Hamad Medical Corporation / National Center for Cancer Care and Research
Qatar's public health system, whose National Center for Cancer Care and Research is the country's sole comprehensive cancer centre and the hub of its national cancer strategy.
Hamad Medical Corporation, established in 1979, runs Qatar's public hospitals, and its National Center for Cancer Care and Research (formerly Al Amal Hospital) is the national cancer centre delivering medical, surgical and radiation oncology, haematology and bone marrow transplant, palliative care and a growing clinical trials programme. Qatar's National Cancer Strategy and National Cancer Program, with Sidra Medicine for paediatrics and the Qatar Biobank and Qatar Genome Programme for research, position HMC as a testbed for population genomics and early-detection initiatives in an Arab population, and NCCCR has been accredited by the Joint Commission and partners with academic centres in Europe and North America on training and trials.
- National Center for Cancer Care and Research
- National cancer strategy
- Bone marrow transplant
- Qatar Genome collaboration
Pages like this
not linked directly; found by shared links- InstitutionRamathibodi Hospital, Mahidol University
Shares Allogeneic (off-the-shelf) cell therapy, Germline (hereditary) testing, Acute myeloid leukaemia, HR-positive / HER2-negative breast cancer.
- InstitutionTata Medical Center, Kolkata
Shares Allogeneic (off-the-shelf) cell therapy, IMRT / IGRT (modern external beam), Acute myeloid leukaemia, Diffuse large B-cell lymphoma.
- InstitutionKing Faisal Specialist Hospital and Research Centre
Shares Allogeneic (off-the-shelf) cell therapy, Germline (hereditary) testing, Diffuse large B-cell lymphoma, HR-positive / HER2-negative breast cancer.
- InstitutionHospital Universitari i Politècnic La Fe
Shares Allogeneic (off-the-shelf) cell therapy, Germline (hereditary) testing, Acute myeloid leukaemia, HR-positive / HER2-negative breast cancer.
- InstitutionKing Hussein Cancer Center
Shares Allogeneic (off-the-shelf) cell therapy, Germline (hereditary) testing, Diffuse large B-cell lymphoma, HR-positive / HER2-negative breast cancer.
- InstitutionRoyal Adelaide Hospital
Shares IMRT / IGRT (modern external beam), Acute myeloid leukaemia, HR-positive / HER2-negative breast cancer, Colorectal cancer.
- InstitutionRambam Health Care Campus
Shares Allogeneic (off-the-shelf) cell therapy, IMRT / IGRT (modern external beam), Acute myeloid leukaemia, HR-positive / HER2-negative breast cancer.
- InstitutionUniversity of Malaya Medical Centre
Shares Germline (hereditary) testing, IMRT / IGRT (modern external beam), HR-positive / HER2-negative breast cancer, Colorectal cancer.